LENSAR, Inc. (LNSR) stock
LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.85−0.06 (-1.22%)
Close on Nov 18, 2026Market cap $59.59MP/E –Yield –
Lensar total assets
Total assets on the balance sheet at the end of each period.
Lensar's total assets was $69.56M at Jun 30, 2026. For fiscal 2025 it was $71.43M, up 7.7% from the year before. The highest annual figure on record is $79.12M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.43M | +7.7% |
| FY2024 | Dec 31, 2024 | $66.30M | -4.7% |
| FY2023 | Dec 31, 2023 | $69.59M | +24.6% |
| FY2022 | Dec 31, 2022 | $55.84M | -16.0% |
| FY2021 | Dec 31, 2021 | $66.47M | -16.0% |
| FY2020 | Dec 31, 2020 | $79.12M | +129.1% |
| FY2019 | Dec 31, 2019 | $34.54M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $69.56M | -1.2% |
| Q1 FY2026 | Mar 31, 2026 | $66.22M | -9.2% |
| Q4 FY2025 | Dec 31, 2025 | $71.43M | +7.7% |
| Q3 FY2025 | Sep 30, 2025 | $70.20M | +13.2% |
| Q2 FY2025 | Jun 30, 2025 | $70.41M | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $72.96M | +10.3% |
| Q4 FY2024 | Dec 31, 2024 | $66.30M | -4.7% |
| Q3 FY2024 | Sep 30, 2024 | $62.02M | -12.5% |
| Q2 FY2024 | Jun 30, 2024 | $61.41M | -13.8% |
| Q1 FY2024 | Mar 31, 2024 | $66.13M | +27.3% |
| Q4 FY2023 | Dec 31, 2023 | $69.59M | +24.6% |
| Q3 FY2023 | Sep 30, 2023 | $70.85M | +29.3% |
| Q2 FY2023 | Jun 30, 2023 | $71.20M | +21.3% |
| Q1 FY2023 | Mar 31, 2023 | $51.96M | -13.8% |
| Q4 FY2022 | Dec 31, 2022 | $55.84M | -16.0% |
| Q3 FY2022 | Sep 30, 2022 | $54.80M | -19.5% |
| Q2 FY2022 | Jun 30, 2022 | $58.70M | -19.0% |
| Q1 FY2022 | Mar 31, 2022 | $60.30M | -18.0% |
| Q4 FY2021 | Dec 31, 2021 | $66.47M | -16.0% |
| Q3 FY2021 | Sep 30, 2021 | $68.10M | -15.6% |
| Q2 FY2021 | Jun 30, 2021 | $72.48M | +109.9% |
| Q1 FY2021 | Mar 31, 2021 | $73.54M | – |
| Q4 FY2020 | Dec 31, 2020 | $79.12M | – |
| Q3 FY2020 | Sep 30, 2020 | $80.71M | – |
| Q4 FY2019 | Dec 31, 2019 | $34.54M | – |
See a number that looks wrong?